Rebif Rebidose Interactions
There are 334 drugs known to interact with Rebif Rebidose (interferon beta-1a), along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 14 are major, 319 are moderate, and 1 is minor.
- View all 334 medications that may interact with Rebif Rebidose
- View Rebif Rebidose alcohol/food interactions (1)
- View Rebif Rebidose disease interactions (4)
Most frequently checked interactions
View interaction reports for Rebif Rebidose (interferon beta-1a) and the medicines listed below.
- albuterol
- alprazolam
- amlodipine
- Ampyra (dalfampridine)
- atorvastatin
- azelastine nasal
- baclofen
- Belviq (lorcaserin)
- biotin
- Contrave (bupropion / naltrexone)
- Cymbalta (duloxetine)
- diazepam
- duloxetine
- gabapentin
- lisinopril
- modafinil
- multivitamin
- Neurontin (gabapentin)
- Omega 3-6-9 Complex (omega-3 polyunsaturated fatty acids)
- oxybutynin
- ProAir HFA (albuterol)
- rizatriptan
- Synthroid (levothyroxine)
- tizanidine
- Topamax (topiramate)
- turmeric
- Valtrex (valacyclovir)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
Rebif Rebidose alcohol/food interactions
There is 1 alcohol/food interaction with Rebif Rebidose (interferon beta-1a).
Rebif Rebidose disease interactions
There are 4 disease interactions with Rebif Rebidose (interferon beta-1a) which include:
More about Rebif Rebidose (interferon beta-1a)
- Rebif Rebidose consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: interferons
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.